Skip to main content
. 2021 Nov 2;9(11):1598. doi: 10.3390/biomedicines9111598

Table 3.

Summary of MSC cell-free therapy for liver fibrosis.

Type Treatment Target/Experimental Model Mechanism Outcome Ref
In vitro MSC-CM HSCs Reducing expressions of
pro-fibrotic genes
Inhibition of
HSCs activation
[131]
Cytokine, TSG-6 HSCs Decreasing HSC activation
Promoting the transdifferentiation of activated HSCs into
stem-like cells
Amelioration of
liver fibrosis
[136]
MSC-exosomes HSCs Inhibiting Wnt/β-catenin signaling Inhibition of
HSC activation
[144]
Co-culture with
miR-125b manipulated MSCs
LX2 Targeting Smo;
suppression of Hh signaling
Inhibition of
HSC activation
[149]
In vivo MSC-CM CCl4-induced liver fibrosis in mice Reducing collagen accumulation and inflammation
Elevating hepatocyte survival
Amelioration of
liver fibrosis
[132]
Cytokine, TSG-6 CCl4-induced liver fibrosis in mice Inducing M2 polarization
Upregulating MMP12 expression in macrophages
Amelioration of
liver fibrosis
[137]
Cytokine, MFGE 8 TAA or CCl4-induced liver fibrosis in mice Downregulating the expression of TGFβR1 of HSC Amelioration of
liver fibrosis
[138]
MSC-exosomes CCl4-induced liver fibrosis in mice Reducing hepatocyte death
Decreasing oxidative stress
Amelioration of
liver fibrosis
[142]
CCl4-induced liver fibrosis in mice Inactivating TGF-β/SMAD
signaling pathway
Amelioration of
liver fibrosis
[143]
CCl4-induced liver fibrosis in rats Suppressing Wnt/β-catenin
signaling
Improvement of
liver function
[144]
GPX1 delivered by the MSC-exosomes CCl4-induced liver fibrosis in mice Decreasing oxidative stress
Increasing hepatocyte proliferation
Amelioration of
liver fibrosis
[145]
miR-150-5p contained in MSC-exosomes CCl4-induced liver fibrosis in mice Reducing the expression of
CXCL-1
Amelioration of
liver fibrosis
[14]
miR-1246 contained in MSC-exosomes ischemia/reperfusion-induced liver injury in mice Modulating the balance of
regulatory T cells and Th17 cells
Protection of hepatocytes Suppression of inflammation [147]
miR-486-5p contained in MSC-exosomes CCl4-induced liver fibrosis in mice Suppressing Hh signaling Amelioration of
liver fibrosis
[148,149]
miR-125b contained in MSC-exosomes CCl4-induced liver fibrosis in rats

MSC, Mesenchymal stem cell; HSC, Hepatic stellate cell; CM, Conditioned media; TSG-6, Tumor necrosis factor-inducible gene 6 protein; miR, MicroRNA; Hh, Hedgehog; Smo, Smoothened; MMP12, Matrix metalloproteinase 12; MFGE8, Milk fat globule EGF factor 8 protein; CCl4, Carbon tetrachloride; TAA, Thioacetamide; TGFβR1, Transforming growth factor beta-receptor 1; TGF-β, Transforming growth factor beta; GPX1, Glutathione peroxidase 1; Th17, T helper 17; CXCL-1, CXC chemokine-ligand-1.